Paspertin 50 mg/10 ml, Infusionslösungskonzentrat - 5 Ampulle(n) |
| 53115012 | | BGP Products GmbH | | Paspertin 50 mg/10 ml, Infusionslösungskonzentrat | | 20.03.1995 | | | | 20.03.1995 | | Metoclopramide (A03FA01) | | 20.01.2005 | | WHO-DDD | | 19.01.2020 | | 01.09. | | 5 Ampulle(n) | | 01.09. | | | | B | | | | No | | | | IP | | | | PR | | | | k.A. | | PR | | FB | | | | 7680531150127 | | Synthetika human | | | | |
|
Composition |
metoclopramidi hydrochloridum 50 mg, natrii chloridum, aqua ad iniectabilia q.s. ad solutionem pro 10 ml. |
Packungsbestandteile |
| Concentrate for infusion | | | | Active Agent | Dose |
---|
Metoclopramide Hydrochloride | 50mg / 10ml |
| | Inactive agents |
---|
Sodium Chloride |
|
|
Source |
Data was imported : 02.09.2015
Swissmedic Registration : 53115
Sequence : 01
Product name : Paspertin 50 mg/10 ml, Infusionslösungskonzentrat
Registration owner: : BGP Products GmbH
Product group :
Index Therapeuticus (BSV) : 01.09.0.
Medication Code : Synthetika human
Date of registration : 20.03.1995
Valid until : 19.01.2020
Package number : 012
Show package size : 5
Commercial Form/Unit : Ampulle(n)
Swissmedic categorie. : B
Active Agents : metoclopramidi hydrochloridum
Composition : metoclopramidi hydrochloridum 50 mg, natrii chloridum, aqua ad iniectabilia q.s. ad solutionem pro 10 ml.
|
|